Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.
- DOI
- 10.1021/acs.jmedchem.6c00407
- Published
- 2026 May 28
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c00407,
title = {Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.},
author = {Chrzanowski J and Nowicka J and Koralewski R and Joachimiak L and Gzik A and Borek B and Brzezinska J and Kusmirek D and Olejniczak S and Matyszewski K and Mazur M and Olczak J and Glatt S and Grudnik P and Wilk P and Muchowicz A and Kikulska A and Gluchowska KM and Drzewicka K and Belczyk-Ciesielska A and Wachowska M and Sipak-Bujanowicz Z and Mulewski K and Tkaczyk A and Rejczak T and Golebiowski A and Zaslona Z and Blaszczyk R},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c00407},
url = {https://doi.org/10.1021/acs.jmedchem.6c00407}
}RIS
TY - JOUR TI - Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity. AU - Chrzanowski J AU - Nowicka J AU - Koralewski R AU - Joachimiak L AU - Gzik A AU - Borek B AU - Brzezinska J AU - Kusmirek D AU - Olejniczak S AU - Matyszewski K AU - Mazur M AU - Olczak J AU - Glatt S AU - Grudnik P AU - Wilk P AU - Muchowicz A AU - Kikulska A AU - Gluchowska KM AU - Drzewicka K AU - Belczyk-Ciesielska A AU - Wachowska M AU - Sipak-Bujanowicz Z AU - Mulewski K AU - Tkaczyk A AU - Rejczak T AU - Golebiowski A AU - Zaslona Z AU - Blaszczyk R PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c00407 UR - https://doi.org/10.1021/acs.jmedchem.6c00407 ER -
APA
J, C., J, N., R, K., L, J., A, G., B, B., J, B., D, K., S, O., K, M., M, M., J, O., S, G., P, G., P, W., A, M., A, K., KM, G., K, D., A, B., M, W., Z, S., K, M., A, T., T, R., A, G., Z, Z., & R, B. (2026). Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00407
Source records
- pubmed · retrieved 2026-09-26T15:58:52.416Z